/ROTH

ROTH Stock - PharmaRoth Labs, Inc.

Q: What is the analyst price target for ROTH?

Analyst price target information is not currently available for ROTH.

Q: What is ROTH's market cap?

Market capitalization information is not currently available for ROTH.

Healthcare|Medical - Pharmaceuticals|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for ROTH

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2013

FY2014

FY2015

FY2016

FY2017

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-3.11

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2017	FY2016	FY2015	FY2014	FY2013
Revenue	$181,563	$263,458	$86,977	$529,047	$153,892
Gross Profit	$72,625	$108,018	$26,925	$316,418	$34,226
Gross Margin	40.0%	41.0%	31.0%	59.8%	22.2%
Operating Income	$-91,576	$-232,905	$-370,010	$-292,537	$-426,713
Net Income	$-91,521	$-232,846	$-369,781	$-290,972	$-425,198
Net Margin	-50.4%	-88.4%	-425.1%	-55.0%	-276.3%
EPS	$-0.00	$-0.00	$-0.00	$-0.00	$-0.00

Company Overview

PharmaRoth Labs, Inc. operates as a nutraceutical company worldwide. It focuses on producing, marketing, and distributing Sucanon, an herbal-based nutraceutical treatment for type-2 diabetes. The company was formerly known as Fero Industries Inc. and changed its name to PharmaRoth Labs, Inc. in March 2013. PharmaRoth Labs, Inc. was founded in 2000 and is based in Las Vegas, Nevada.

Visit Website

Frequently Asked Questions about ROTH

What is ROTH's current stock price?

PharmaRoth Labs, Inc. (ROTH) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for ROTH?

No analyst price targets are currently available for this stock.

What sector is PharmaRoth Labs, Inc. in?

PharmaRoth Labs, Inc. operates in the Healthcare sector, specifically within the Medical - Pharmaceuticals industry. The company is traded on the OTC exchange.

What is ROTH's market cap?

PharmaRoth Labs, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does ROTH pay dividends?

No, PharmaRoth Labs, Inc. does not currently pay a dividend to shareholders.